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The structure of the complex between E. cofi (RT500) form I dihydrofolate reductase, the antibacterial 
trimethoprim and NADPH has been determined by X-ray crystallography. The inhibitor and cofactor are 
in mutual contact. A flexible chain segment which includes Met 20 is in contact with the-inhibitor in the 
presence of NADPH, but more distant in its absence. By contrast, the inhibitor conformation is little 
changed with NADPH present. We discuss these observations with regard to the mutually cooperative bind- 
ing of these ligands to the protein, and to the associated enhancement of inhibitory selectivity shown by 
trimethoprim for bacterial as opposed to vertebrate nzyme. 
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1. INTRODUCTION 
Dihydrofolate reductase (EC 1.5.1.3) (DHFR) is 
an intracellular receptor for a number of drug 
molecules. Inhibition of the DHFR-catalysed reac- 
tion, the NADPH-dependent reduction of 
dihydrofolate, attenuates the biosynthesis of 
purines, thymidylate and certain amino acids [ 11. 
Some drugs show selective inhibition of DHFR 
from different species; for example, trimethoprim 
(TMP) is used as an antibacterial and 
pyrimethamine as an antimalarial [2]. For TMP an 
approx. 3OOO-fold difference in Ki has been 
reported for mammalian compared with bacterial 
(E. coli) DHFR [3]. Cooperativity between in- 
hibitor binding and cofactor binding has been 
observed for a variety of DHFR ligands [3-61 and 
it has been shown that a component of the selec- 
tivity depends upon the cooperative binding to 
DHFR of TMP and reduced cofactor, NADPH. 
This cooperativity is larger with E. coli than with 
mammalian enzyme [3]. It is not known whether 
cooperativity between cofactor binding and TMP 
binding arises through direct interaction between 
Dihydrofolate reductase Cooperativity 
the ligands at the active site or through conforma- 
tional changes induced in the enzyme. Certainly, 
NMR studies have indicated the accessibility of 
more than one conformational state of the enzyme 
in some ternary complexes ([7-91; also G.C.K. 
Roberts, personal communication). 
We reported previously the crystal structure of 
the TMP-bound E. coli DHFR enzyme in the 
absence of NADPH [lO,l I]. More recently, this 
structure has been compared with the complex of 
TMP with NADPH and chicken DHFR [12]. This 
showed subtle differences in the binding sites for 
the drug, and these give rise to different drug con- 
formations. Bolin et al. [13] have also compared a 
binary E. coli DHFR-methotrexate complex with a 
ternary L. cusei DHFR-methotrexate-NADPH 
complex. We report here the structure of the ter- 
nary E. co/i DHFR-TMP-NADPH complex, com- 
pare this with the binary E. coli DHFR-TMP com- 
plex and discuss possible structural contributions 
to cooperative binding. Attempts to diffuse 
NADPH into pre-grown E. coli DHFR-TMP 
binary complex (hexagonal) crystals resulted in 
loss of crystallinity. Co-crystallisation of the ter- 
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nary DHFR-TMP-NADPH complex gave rise to a 
new crystal form requiring de novo structure 
determination. 
2. EXPERIMENTAL 
2. I. C~ysiallisaiion a d data collection 
E. coli (RTSOO) form 1 DHFR [14] was 
crystallised from aqueous ethanol solutions at 
4°C. Enzyme (20 mg/ml) was dialysed against 3 
changes of 1 mM NADPH, 1 mM TMP, 3.6 mM 
CaClz in 50 mM Hepes buffer (Nat-), pH 6.8, 
with 10% ethanol overnight. The solution was cen- 
trifuged at 20000 x g for 30 min. 5021 droplets 
were placed in a vapour diffusion apparatus and 
the reservoir contained variously 15, 17, 19 and 
21% aqueous ethanol. Crystals grew as large 
trigonal bipyramids up to 2 mm long during a 
period of several weeks. The integrity of the co- 
crystallised NADPH over this time was 
demonstrated by spectral absorption at 340 nm 
after one such crystal had been dried and redis- 
solved, The space group of the crystals was deter- 
mined to be P3r21 or P322I with cell dimensions a 
= 61.8 A and c = 105.8 A having one enzyme 
molecule in the asymmetric unit. CuKcv X-ray dif- 
fraction data to 3.0 A resolution were collected 
using an Arndt-Wonacott rotation camera [15]. 
Upon data reduction, the R factor (R = 
C IF - Fi I /Cf;i) for data collected from two native 
crystals and subsequently merged was 0.113 (5007 
unique data, each arising from typically 4 or 5 
reflexions). Two heavy-atom derivative data sets 
were collected from crystals which had been 
soaked in ethylmer~uriphosphate or p-chloro- 
mercuribenzoate and which gave rise to X-ray in- 
tensity differences. 
2.2. Structure soiution 
Early attempts to solve reflexion phases by use 
of the isomorphous heavy-atom derivatives of 
these crystals failed, since the difference-Patterson 
maps eluded interpretation. It was therefore decid- 
ed to use the procedure of ‘molecular replacement’ 
to discover the orientation and location of a 
known related structure, the protein part of the 
previously determined binary E. coli DHFR-TMP 
complex, in the ternary complex unit cell, and use 
the atomic coordinates to calculate phases. 
Crowther’s method [16] was used to determine the 
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rotation of the molecule, and an R factor search 
[17] in 3 dimensions in each of the space groups 
P322 1 and P3 121 was used to determine its transla- 
tion. The rotation procedure calculated a map with 
grid separation in spherical poiar coordinates of 
5”. A complete vector-space search was done ig- 
noring the inherent symmetry within the unit cell. 
Thus it was possible to identify 6 peaks in the map 
that were related by point group 32 symmetry, and 
whose coordinates could be transformed by the ap- 
propriate symmetry operation to a common value. 
The process gave rise to an initial approximate 
solution, derived from the highest peaks in the 
rotation function. This orientation was applied to 
the known molecule which was then subjected to a 
translation search by structure factor calculation 
within the unit cell of the ternary complex crystal. 
For each space group it was necessary to scan half 
the unit cell volume at approx. 1 .l A intervals; 
thus nearly 1.4 x lo4 translations required to be ex- 
amined. For each translation, 1090 structure fac- 
tors to 4 A resolution were calculated. The pro- 
cedure gave an unequivocal minimum R factor for 
one particular grid point in space group P3221. 
At this point the orientation and translation 
were used to determine reflexion phases, and dif- 
ference maps were calculated for each of the two 
mercury-containing derivatives. Two clear peaks 
emerged in the ethylmercuriphosphate map and 
one in that of p-chloromercuribenzoate. The peak 
common to each derivative appeared to be close to 
Cys 85 which supported the molecular replacement 
solution. As a further check, this solution was 
found to avoid interpenetration of molecules. The 
approximate solution was further refined using a 
selected shell of data between 6 and 4.5 A resolu- 
tion, which reduced the R factor from 0.41 to 0.34 
against a background R factor of 0.43 and above 
for incorrect solutions. 
2.3. Model building 
Several ‘omit’ electron density maps, one for 
each region requiring interpretation, were 
calculated from all observed X-ray data to 3.0 A, 
with phases determined from atoms of the struc- 
ture (90-95%) outside the region under scrutiny. 
Detailed fitting to the electron density in the omit 
regions was performed at Oxford University on an 
Evans and Sutherland PS2 display linked to a PDP 
1 l/70; later this work was transferred to an Evans 
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and Sutherland PS300 linked to an in-house VAX 
11/750. In each case the molecule fitting was 
achieved through use of the program FRODO [ 181. 
Adjustment was stopped with an R factor of 0.44 
for all data to 3 A resolution. 
3. RESULTS 
3.1. Trimethoprim 
The principal torsion angles (71 and 72) between 
the rings of TMP differ rather little between the 
binary and ternary complexes of TMP with E. cofi 
DHFR. For the binary complex they are respec- 
tively [12] 177 and 76” and in the presently unre- 
fined ternary complex model 192 and 56”. This 
slight difference of torsion angles leads to small 
changes in the contacts between TMP and those 
neighbouring residues which remain essentially un- 
shifted in the two types of complex. One m- 
methoxy group is positioned in van der Waals con- 
tact with the side chains of Leu 28 and Phe 31, 
slightly shifted from its binary complex location 
close to Ile 50 and Leu 54 side chains; the other is 
repositioned midway between peptide 49/50 and 
the newly located Met 20 side chain (see below and 
figs 1 and 2). 
3.2. Cofactor 
The binding of reduced cofactor to E. coli 
DHFR had not previously been determined by X- 
ray crystallography, although other studies have 
shown how NADPH binds to L. casei [19], chicken 
[20,21] and mouse L1210 [22] enzymes. The loca- 
tion and conformation of the cofactor appear to be 
similar in all cases, including E. coli enzyme, and 
the rms deviations between molecules of DHFR- 
bound cofactor superimposed one on the other are 
0.9 A for E. coli DHFR compared with L. casei 
DHFR, and 1.2 A compared with chicken DHFR. 
The corresponding value for L. casei enzyme vs 
chicken enzyme is 1 .O A. (See table 1 for details of 
the superposition method.) As indicated by Filman 
et al. [19] the residues and contacts involved in 
cofactor binding are highly conserved. In common 
with the other ternary complexes determined, the 
reduced end of the cofactor is close to the 
pyrimidine ring of the inhibitor and the amide is 
probably hydrogen-bonded to the main chain of 
Ala 7, as reported for L. casei enzyme [19]. The 
nicotinamide group is also close to the bridging 
methylene of TMP and one edge of the benzene 
ring as well as to one m-methoxy group. 
3.3. Protein 
Over the majority of the protein structure the 
chain folding differs little from that observed for 
the E. co/i binary complex. A marked difference is 
observed however in the vicinity of residues 15-21, 
and as can be seen from fig. 1 the change in confor- 
Fig. 1. Stereo skeletal representation f part of the active site of E. coli DHFR in ternary complex with TMP and 
cofactor NADPH. The two ligand molecules are drawn with bold lines. 
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Fig.2. Stereo skeletal representation f part of the active site of the binary E. coli DHFR-TMP complex. TWO 
crystallographically independent molecules are observed, (a) molecule I and (b) molecule II (121. The TMP skeletons 
are shown in bold lines. 
mation of the peptide chain in this region brings 
Met 20 into contact with the inhibitor and with the 
nicotinamide moiety of the cofactor. Residues 
15-21 are not directly involved in intermolecular 
packing as they are in the binary complex. In sec- 
tion 4 the segment of chain containing these 
residues, and its counterpart in other DHFRs, will 
be termed the ‘flexible loop’. 
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4. DISCUSSION 
Table 1 compares flexible loop regions of 
various DHFR complexes, including those of E. 
coli. The smallest rms difference (0.7 A) occurs 
between the two ternary complexes of highest 
resolution; however, rms differences not much 
greater occur between either of these and the 
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Table 1 
The rms differences in a-carbon positions (A) of residues in the sequence 13-23 (E. cofi numbering) between DHFR 
molecules superimposed from different crystal structures 
DHFR complex E. coli DHFR molecules in DHFR molecules in 
(resolution) binary complex with TMP ternary complex 
(2.3 A resolution) [12] 
E. cob/ L. casei/ 
Molecule Molecule TMP/NADPH MTX/NADPH 
I II 
E. coli binary molecule II (2.3 A) 1.8 
E. coli ternary (3.0 A) 2.4 1.8 
L. casei ternary (1.7 A) [13] 2.7 2.2 1.0 
Chicken ternary (2.2 A) [12]; 
10 residues only 2.8 2.2 1.1 0.7 
Each value was obtained after superposition of a pair of complexes o that the discrepancy between each whole set of 
a-carbons was minimised, followed by a further translation to achieve closer coincidence of the particular region of 
interest. The residual rms value then provides a comparison of conformations (The numbering of the distinct E. coli 
binary molecules follows the convention of Matthews et al. [12].) 
unrefined, lower-resolution, E. coli ternary struc- 
ture, for which errors in atomic positions will be 
somewhat larger. The tabulated differences point 
to a common conformation in complexes that con- 
tain NADPH and inhibitor, a conformation dif- 
ferent from those observed in the E. cofi binary 
complex which lacks NADPH. Moreover, the two 
crystallographically distinct molecules in the 
binary complex show conformations in this region 
substantially different from each other. This gives 
rise to the idea of a mobile region which can adopt 
different conformations in the absence of cofactor 
but which folds in a distinct fashion in a ternary 
complex. It happens that the flexible loops of 
molecules I and II of the binary complex are in- 
volved in intermolecular packing whereas this loop 
in the ternary complex is remote from adjacent 
molecules. Certainly, our attempts to prepare the 
ternary complex crystals by diffusion of NADPH 
into hexagonal crystals of the binary complex 
resulted in disorder, presumably because a 
cofactor-induced conformational change in the 
flexible loop disrupted important intermolecular 
interactions. Conversely, no trigonal crystals were 
observed during crystallisation of the binary com- 
plex, despite the use of similar conditions of 
growth, and it may be reasonable to suppose that 
the ternary conformer of the flexible loop is not 
favoured in the absence of cofactor. 
To what extent might such conformational flex- 
ibility within the enzyme contribute to cooperativi- 
ty between cofactor binding and inhibitor binding? 
Some published values for cooperativity are given 
in table 2. If we compare the interactions between 
TMP and the enzyme in the ternary conformation 
with those observed for TMP with the binary con- 
former we note that the overall interaction is 
Table 2 
Some cooperative interactions between trimethoprim, 






















a Binary complex is with inhibitor except for L. casei [4] 
where it is with NADPH 
b Ratio of binary and ternary dissociation rate constants 
’ Ratio of dissociation constants 
* Isozyme forms 1 and 2 of E. coli (RTSOO) DHFR differ 
by a single amino acid substitution [14] 
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enhanced by the additional contacts between 
ligand and enzyme provided by the ternary con- 
former (notably between the substituted trimeth- 
oxybenzene and the side chain of Met 20). Further- 
more, one would predict that NADPH binding in 
the ternary complex is enhanced by interactions 
additional to those that would be made with the 
binary conformer (notably between the ribose and 
residues 17 and 18 of the flexible loop, and be- 
tween the nicotinamide and side chain of Met 20). 
Progressive binding of ligands, by favouring the 
ordered conformer, would increase the proportion 
of this tighter-binding species, and a positive 
cooperativity would result. Observations on a 
variety of DHFR-NADPH-inhibitor complexes 
[ 12,19-221 show that the nicotinamide of cofactor 
interacts with some part of the inhibitor, and no 
doubt a component of cooperativity arises from 
direct interaction between both types of bound 
ligand. The negative cooperativity observed for the 
binding of certain substrate analogues [6] might be 
explained by direct steric interference between in- 
hibitor and cofactor, or a preference of the in- 
hibitor for the flexible conformer. 
With TMP binding, smaller positive values for 
cooperativity are obtained for mouse than for E. 
coli enzyme (table 2). In the chicken enzyme ter- 
nary complex, as with mouse, the conformation of 
TMP is substantially different from that in the E. 
coli enzyme complex [12]. This gives rise to a dif- 
ferent position and orientation for the trimethox- 
ybenzyl group. Moreover, the pyrimidine is 
somewhat differently located. This TMP con- 
former is readily accommodated in a cleft 
significantly larger than that of E. coli DHFR. 
However, this is at the expense of certain interac- 
tions with the cofactor and with the flexible loop. 
Leu 22 (homologous to Met 20 of E. coli enzyme), 
whilst able to interact with the nicotinamide of 
NADPH, is somewhat distant from TMP (4 A 
from the bridging methylene). Thus, the lower 
cooperativity exhibited in vertebrate nzyme ligand 
binding might be due to a decrease in the number 
of contacts between inhibitor, cofactor and en- 
zyme compared with the analogous E. coli com- 
plex, although possible contributions may also 
arise from intrinsic energy differences for the con- 
formational transition. 
Further understanding of the cooperativity 
could result from determination of the structures 
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of the E. coli apoenzyme and of the corresponding 
DHFR-NADPH binary complex. 
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